C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies

International Journal of Cardiology

Volumn 190, Issue 1, 2015, Pages 264-267

  Xu, Tian ^a   Ke, Kaifu ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

C reactive protein; Dose response meta analysis; Ischemic stroke; Prospective studies

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; BIOLOGICAL MARKER;

AGE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; GENDER; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; LETTER; META ANALYSIS (TOPIC); PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD; HEALTH SURVEY; META ANALYSIS; METABOLISM; OBSERVATIONAL STUDY; PROCEDURES; PROSPECTIVE STUDY; STROKE;

BIOMARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84929171050     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.04.176     Document Type: Article

References (24)

1. T. Xu, X. Bu, H. Li, M. Zhang, A. Wang, W. Tong, et al., Smoking, heart rate, and ischemic stroke: a population-based prospective cohort study among Inner Mongolians in China, Stroke 44 (2013) 2457-2461.
2. A. Wang, T. Xu, M. Zhang, H. Li, W. Tong, Y. Zhang, Hypertension and elevated Creactive protein: future risk of ischemic stroke in a prospective cohort study among inner Mongolians in China, Int. J. Cardiol. 174 (2014) 455-456.
3. S. Greenland, Quantitative methods in the review of epidemiologic literature, Epidemiol. Rev. 9 (1987) 1-30.
4. S. Greenland, M.P. Longnecker, Methods for trend estimation from summarized dose-response data, with applications to meta-analysis, Am. J. Epidemiol. 135 (1992) 1301-1309.
5. N. Orsini, R. Bellocco, S. Greenland, Generalized least squares for trend estimation of summarized dose-respose data, Stata J. 6 (2006) 40-57.
6. N. Orsini, R. Li, A. Wolk, P. Khudyakov, D. Spiegelman, Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software, Am. J. Epidemiol. 175 (2012) 66-73.
7. J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, Measuring inconsistency in meta-analyses, BMJ 327 (2003) 557-560.
8. J.P. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta-analysis, Stat. Med. 21 (2002) 1539-1558.
9. C.B. Begg, M. Mazumdar, Operating characteristics of a rank correlation test for publication bias, Biometrics 50 (1994) 1088-1101.
10. B.M. Everett, T. Kurth, J.E. Buring, P.M. Ridker, The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women, J. Am. Coll. Cardiol. 48 (2006) 2235-2242.
11. J.J. Cao, C. Thach, T.A. Manolio, B.M. Psaty, L.H. Kuller, P.H. Chaves, et al., C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study, Circulation 108 (2003) 166-170.
12. Y. Wakugawa, Y. Kiyohara, Y. Tanizaki, M. Kubo, T. Ninomiya, J. Hata, et al., Creactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study, Stroke 37 (2006) 27-32.
13. H. Iso, H. Noda, A. Ikeda, K. Yamagishi, M. Inoue, M. Iwasaki, et al., The impact of Creactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study, J. Atheroscler. Thromb. 19 (2012) 756-766.
14. C.L. Chei, K. Yamagishi, A. Kitamura, M. Kiyama, H. Imano, T. Ohira, et al., C-reactive protein levels and risk of stroke and its subtype in Japanese: the Circulatory Risk in Communities Study (CIRCS), Atherosclerosis 217 (2011) 187-193.
15. C.C. Patterson, A.E. Smith, J.W. Yarnell, A. Rumley, Y. Ben-Shlomo, G.D. Lowe, The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study, Atherosclerosis 209 (2010) 551-557.
16. S. Makita, M. Nakamura, K. Satoh, F. Tanaka, T. Onoda, K. Kawamura, et al., Serum Creactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population, Atherosclerosis 204 (2009) 234-238.
17. J. Andersson, L. Johansson, P. Ladenvall, P.G. Wiklund, B. Stegmayr, C. Jern, et al., Creactive protein is a determinant of first-ever stroke: prospective nested casereferent study, Cerebrovasc. Dis. 27 (2009) 544-551.
18. Y. Liu, J. Wang, L. Zhang, C. Wang, J. Wu, Y. Zhou, et al., Relationship between Creactive protein and stroke: a large prospective community based study, PLoS One 9 (2014) e107017.
19. S. Jiang, Y. Bao, X. Hou, Q. Fang, C. Wang, J. Pan, et al., Serum C-reactive protein and risk of cardiovascular events in middle-aged and older Chinese population, Am. J. Cardiol. 103 (2009) 1727-1731.
20. H. Iso, R. Cui, C. Date, S. Kikuchi, A. Tamakoshi, C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study, Atherosclerosis 207 (2009) 291-297.
21. M.J. Bos, C.M. Schipper, P.J. Koudstaal, J.C. Witteman, A. Hofman, M.M. Breteler, High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study, Circulation 114 (2006) 1591-1598.
22. N. Sattar, H.M. Murray, A. McConnachie, G.J. Blauw, E.L. Bollen, B.M. Buckley, et al, Creactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER), Circulation 115 (2007) 981-989.
23. J. Hartweg, M. Gunter, R. Perera, A. Farmer, C. Cull, C. Schalkwijk, et al., Stability of soluble adhesion molecules, selectins, and C-reactive protein at various temperatures: implications for epidemiological and large-scale clinical studies, Clin. Chem. 53 (2007) 1858-1860.
24. Q. Li, T. Kang, X. Tian, Y. Ma, M. Li, J. Richards, et al., Multimeric stability of human Creactive protein in archived specimens, PLoS One 8 (2013) e58094.